Terms: = Uterine cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
30 results:
1. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract] [Full Text] [Related]
2. Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?
Vrede SW; Donkers H; Reijnen C; Smits A; Visser NCM; Geomini PM; Ngo H; van Hamont D; Pijlman BM; Vos MC; Snijders MPLM; Kruitwagen R; Bekkers RLM; Galaal K; Pijnenborg JMA
J Obstet Gynaecol; 2024 Dec; 44(1):2294332. PubMed ID: 38186008
[TBL] [Abstract] [Full Text] [Related]
3. Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.
Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Carvalho L; Salgado L; Pereira D; Medeiros R
Sci Rep; 2023 Jun; 13(1):9519. PubMed ID: 37308506
[TBL] [Abstract] [Full Text] [Related]
4. Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas.
Wu Y; Li H; Tan L; Lai Y; Li Z
Hum Pathol; 2023 Jan; 131():87-97. PubMed ID: 36370822
[TBL] [Abstract] [Full Text] [Related]
5. Microcystic, elongated and fragmented (MELF) pattern in endometrial carcinoma: clinicopathologic analysis and prognostic implications.
Song J; Li H; Guo H; Cai Y
Medicine (Baltimore); 2022 Oct; 101(43):e31369. PubMed ID: 36316927
[TBL] [Abstract] [Full Text] [Related]
6. High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma.
Ghafour AA; Odemis DA; Tuncer SB; Kurt B; Saral MA; Erciyas SK; Erdogan OS; Celik B; Saip P; Yazici H
J Ovarian Res; 2021 Oct; 14(1):131. PubMed ID: 34629107
[TBL] [Abstract] [Full Text] [Related]
7. Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.
Slomovitz BM; Chelariu-Raicu A; Schmeler KM; Lu KH; Gershenson DM; Wolf J; Coleman RL
Int J Gynecol Cancer; 2020 Nov; 30(11):1733-1737. PubMed ID: 33020204
[TBL] [Abstract] [Full Text] [Related]
8. prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National cancer Database.
Seagle BL; Alexander AL; Lantsman T; Shahabi S
Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of microRNAs in cervical carcinoma: a systematic review and meta-analysis.
Dai S; Lu Y; Long Y; Lai Y; Du P; Ding N; Yao D
Oncotarget; 2016 Jun; 7(23):35369-78. PubMed ID: 27177085
[TBL] [Abstract] [Full Text] [Related]
10. High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer.
Sakaguchi I; Motohara T; Saito F; Takaishi K; Fukumatsu Y; Tohya T; Shibata S; Mimori H; Tashiro H; Katabuchi H
J Gynecol Oncol; 2015 Jul; 26(3):193-200. PubMed ID: 25686399
[TBL] [Abstract] [Full Text] [Related]
11. HER2-positive endometrial cancer subtype carries poor prognosis.
Lapińska-Szumczyk S; Supernat A; Majewska H; Gulczyński J; Luczak A; Biernat W; Wydra D; Zaczek AJ
Clin Transl Sci; 2014 Dec; 7(6):482-8. PubMed ID: 25201050
[TBL] [Abstract] [Full Text] [Related]
12. Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.
Roque DM; Bellone S; English DP; Buza N; Cocco E; Gasparrini S; Bortolomai I; Ratner E; Silasi DA; Azodi M; Rutherford TJ; Schwartz PE; Santin AD
Cancer; 2013 Jul; 119(14):2582-92. PubMed ID: 23585021
[TBL] [Abstract] [Full Text] [Related]
13. Association between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study.
Kawamura L; Carvalho FM; Alves BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
World J Surg Oncol; 2010 Oct; 8():89. PubMed ID: 20946633
[TBL] [Abstract] [Full Text] [Related]
14. Peritumoral lymphatic vessel density as a prognostic parameter in endometrial carcinoma: an immunohistochemical study.
Maghraby HK; Elsarha AI; Saad RS
Indian J Pathol Microbiol; 2010; 53(3):465-9. PubMed ID: 20699504
[TBL] [Abstract] [Full Text] [Related]
15. [Significance of hysteroscopic resection in diagnostics of endometrial cancer].
Dvorská M; Driák D; Svandová I; Sehnal B; Holý P; Benková K; Spůrková Z; Halaska M
Ceska Gynekol; 2010 Apr; 75(2):105-8. PubMed ID: 20518262
[TBL] [Abstract] [Full Text] [Related]
16. [Anti-steroid hormones for uterine cancer].
Komiyama S; Nishio E; Yasue A; Hasegawa K; Udagawa Y
Nihon Rinsho; 2008 Jan; 66(1):174-81. PubMed ID: 18186261
[TBL] [Abstract] [Full Text] [Related]
17. Feasibility of RNA collection for micro-array gene expression analysis in the treatment of cervical carcinoma: a scientific correlate of RTOG C-0128.
Gaffney DK; Winter K; Fuhrman C; Flinner R; Greven K; Ryu J; Forbes A; Kerlin K; Nichols RC; Zempolich K
Gynecol Oncol; 2005 May; 97(2):607-11. PubMed ID: 15863167
[TBL] [Abstract] [Full Text] [Related]
18. Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study.
Viegas CM; Araujo CM; Dantas MA; Froimtchuk M; Oliveira JA; Marchiori E; Souhami L
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1154-9. PubMed ID: 15519787
[TBL] [Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor and prognosis of cervical carcinoma.
Cheng WF; Chen CA; Lee CN; Wei LH; Hsieh FJ; Hsieh CY
Obstet Gynecol; 2000 Nov; 96(5 Pt 1):721-6. PubMed ID: 11042307
[TBL] [Abstract] [Full Text] [Related]
20. Endometrial cancer.
Bristow RE
Curr Opin Oncol; 1999 Sep; 11(5):388-93. PubMed ID: 10505777
[TBL] [Abstract] [Full Text] [Related]
[Next]
